Download Gene Section TSPAN1 (tetraspanin 1) Atlas of Genetics and Cytogenetics

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Gene therapy of the human retina wikipedia , lookup

Designer baby wikipedia , lookup

Polycomb Group Proteins and Cancer wikipedia , lookup

Protein moonlighting wikipedia , lookup

Frameshift mutation wikipedia , lookup

Public health genomics wikipedia , lookup

Genome (book) wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Expanded genetic code wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

Genetic code wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Neuronal ceroid lipofuscinosis wikipedia , lookup

Mir-92 microRNA precursor family wikipedia , lookup

RNA-Seq wikipedia , lookup

Point mutation wikipedia , lookup

Oncogenomics wikipedia , lookup

NEDD9 wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Gene Section
Mini Review
TSPAN1 (tetraspanin 1)
David Murray, Peter Doran
UCD School of Medicine and Medical Sciences, UCD-Mater Clinical Research Centre, Mater Misericordiae
University Hospital, Dublin 7, Ireland
Published in Atlas Database: January 2008
Online updated version: http://AtlasGeneticsOncology.org/Genes/TSPAN1ID44178ch1p34.html
DOI: 10.4267/2042/38580
This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence.
© 2008 Atlas of Genetics and Cytogenetics in Oncology and Haematology
tetraspanin family. These are cell-surface proteins that
are characterized by the presence of four hydrophobic
domains. The proteins mediate signal transduction
events that play a role in the regulation of cell
development, activation, growth and motility.
Identity
Hugo: TSPAN1
Other names: 9030418M05Rik;
322N21.1; TSPAN-1
Location: 1p34.1
NET-1;
RP11-
Homology
Holomogy with Pan troglodytes (100%); Canis lupus
familiaris (89%); Mus musculus (82%), Rattus
norvegicus (82%), Gallus gallus (70%).
DNA/RNA
Description
The TSPAN1 gene is located on chromosome 1 in a
5419 bp sequence (46418799..46424217). The gene
contains 10 exons.
Mutations
Note: TSPAN1 is subject to the following misense
mutations :
Transcription
mRNA: 1297 nucleotides in length.
Source ID
Protein
Description
241 amino acids, 26.2 kDa protein.
The 241 amino acid sequence is:
1 mqcfsfiktm milfnllifl cgaallavgi wvsidgasfl
mqfvnvgyfl;
61 iaagvvvfal gflgcygakt eskcalvtff filllifiae
ttmaehfltl;
121 lvvpaikkdy gsqedftqvw nttmkglkcc gftnytdfed
ppfccndnvt;
181 ntanetctkq kahdqkvegc fnqllydirt navtvggvaa
ivsmylycnl;
241 q
kifgplsssa
vaaavvalvy
rs2234267
rs2234268
rs1047216
Wild type
nucleotide
A
C
G
A
Wild type
amino acid
M
S
V
K
Variant
nucleotide
G
T
A
G
Variant
amino acid
V
F
M
E
Amino
Acid
Position
0
37
86
188
spyfkensaf
gigglelaam
Expression
Widely expressed.
Implicated in
Localisation
Cervical cancer
Plasma membrane.
Disease
Cervical cancer is a malignant carcinoma or the cervix,
typically composed of squamous cells. Most studies
Function
The protein encoded by this gene is a member of the
transmembrane 4 superfamily, also known as the
Atlas Genet Cytogenet Oncol Haematol. 2008;12(5)
rs2234266
391
TSPAN1 (tetraspanin 1)
Murray D, Doran P
have found that human papillomavirus (HPV) infection
is responsible for virtually all cases of cervical cancer.
Prognosis
Prognosis depends on the stage of the cancer. The 5
year survival rate with treatment is 80 to 90% in
patients with stage I disease and 50 to 65% in patients
with stage II disease. 25 to 35% of women with stage
III cancer and 15% or fewer of those with stage IV
cancer are alive after 5 years. Prognosis drops
dramatically with tumour metastasis. Thirty-five
percent of patients with invasive cervical cancer have
persistent or recurrent disease after treatment.
Prognosis
The prognosis of HCC is dependent on many factors,
including tumour size, tumour staging, the involvement
of liver vessels, the presence of extrahepatic metastases
and the vascularisation of the tumor.
References
Wollscheid V, Kühne-Heid R, Stein I, Jansen L, Köllner S,
Schneider A, Dürst M. Identification of a new proliferationassociated protein NET-1/C4.8 characteristic for a subset of
high-grade cervical intraepithelial neoplasia and cervical
carcinomas. Int J Cancer 2002;99(6):771-775.
Chen L, Wang Z, Zhan X, Li DC, Zhu YY, Zhu J. Association of
NET-1 gene expression with human hepatocellular carcinoma.
Int J Surg Pathol 2007;15(4):346-353.
Hepatocellular carcinoma
Disease
Hepatocellular carcinoma (HCC) is a malignancy of the
liver. Most cases of HCC are secondary to either a
hepatitis B or C infection or cirrhosis.
Atlas Genet Cytogenet Oncol Haematol. 2008;12(5)
This article should be referenced as such:
Murray D, Doran P. TSPAN1 (tetraspanin 1). Atlas Genet
Cytogenet Oncol Haematol.2008;12(5):391-392.
392
Related documents
Leukaemia Section t(1;21)(p35;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(p35;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Genes Section DDX10 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 10) Atlas of Genetics and Cytogenetics
Genes Section DDX10 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 10) Atlas of Genetics and Cytogenetics
Gene Section CBLb (Cas-Br-M (murine) ecotropic retroviral transforming sequence b)
Gene Section CBLb (Cas-Br-M (murine) ecotropic retroviral transforming sequence b)
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;5)(q25;q34)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;5)(q25;q34) Atlas of Genetics and Cytogenetics
Leukaemia Section t(1;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section AF15q14 (ALL1 fused gene from 15q14) in Oncology and Haematology
Gene Section AF15q14 (ALL1 fused gene from 15q14) in Oncology and Haematology
Leukaemia Section t(18;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(18;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section CARS (cysteinyj-tRNA synthetase) Atlas of Genetics and Cytogenetics
Gene Section CARS (cysteinyj-tRNA synthetase) Atlas of Genetics and Cytogenetics
Gene Section CASC3 (cancer susceptibility candidate 3) Atlas of Genetics and Cytogenetics
Gene Section CASC3 (cancer susceptibility candidate 3) Atlas of Genetics and Cytogenetics
Gene Section LCP1 (lymphocyte cytosolic protein1) Atlas of Genetics and Cytogenetics
Gene Section LCP1 (lymphocyte cytosolic protein1) Atlas of Genetics and Cytogenetics
Gene Section EPS15 (epidermal growth factor receptor pathway substrate 15)
Gene Section EPS15 (epidermal growth factor receptor pathway substrate 15)
Leukaemia Section t(12;20)(q15;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;20)(q15;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section JARID1A (jumonji, AT rich interactive domain 1A (RBBP2-like))
Gene Section JARID1A (jumonji, AT rich interactive domain 1A (RBBP2-like))
KAVI website HPV Forum Summary
KAVI website HPV Forum Summary
Cancer Prone Disease Section Kidney: t(X;1)(p11.2;p34) in renal cell carcinoma
Cancer Prone Disease Section Kidney: t(X;1)(p11.2;p34) in renal cell carcinoma
Solid Tumour Section Uterus: Carcinoma of the cervix in Oncology and Haematology
Solid Tumour Section Uterus: Carcinoma of the cervix in Oncology and Haematology
Leukaemia Section +9 or trisomy 9 Atlas of Genetics and Cytogenetics
Leukaemia Section +9 or trisomy 9 Atlas of Genetics and Cytogenetics
Solid Tumour Section Uterus: Carcinoma of the cervix in Oncology and Haematology
Solid Tumour Section Uterus: Carcinoma of the cervix in Oncology and Haematology
Gene Section STOML2 (stomatin (EPB72) like 2) -
Gene Section STOML2 (stomatin (EPB72) like 2) -
PHASE III TRIAL OF ANTICANCER AGENT LENVIMA® AS FIRST
PHASE III TRIAL OF ANTICANCER AGENT LENVIMA® AS FIRST
Anatomy of the Atlas Subluxation
Anatomy of the Atlas Subluxation